IS5289A - Method of administration and method for the treatment of viral and microbial infections and corrosion syndromes - Google Patents

Method of administration and method for the treatment of viral and microbial infections and corrosion syndromes

Info

Publication number
IS5289A
IS5289A IS5289A IS5289A IS5289A IS 5289 A IS5289 A IS 5289A IS 5289 A IS5289 A IS 5289A IS 5289 A IS5289 A IS 5289A IS 5289 A IS5289 A IS 5289A
Authority
IS
Iceland
Prior art keywords
syndromes
viral
corrosion
administration
treatment
Prior art date
Application number
IS5289A
Other languages
Icelandic (is)
Inventor
Olga Patricia Giesteira Visser Michelle
Original Assignee
Virodene Pharmaceutical Holdings (Proprietary) Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/874,425 external-priority patent/US5935597A/en
Application filed by Virodene Pharmaceutical Holdings (Proprietary) Limited filed Critical Virodene Pharmaceutical Holdings (Proprietary) Limited
Publication of IS5289A publication Critical patent/IS5289A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/095Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10Sulfides; Sulfoxides; Sulfones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/164Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Anesthesiology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
IS5289A 1997-06-13 1999-12-08 Method of administration and method for the treatment of viral and microbial infections and corrosion syndromes IS5289A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/874,425 US5935597A (en) 1995-12-15 1997-06-13 Drug delivery devices and methods for treatment of viral and microbial infections and wasting syndromes
PCT/US1998/011956 WO1998056325A1 (en) 1997-06-13 1998-06-09 Drug delivery devices and methods for treatment of viral and microbial infections and wasting syndromes

Publications (1)

Publication Number Publication Date
IS5289A true IS5289A (en) 1999-12-08

Family

ID=25363728

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5289A IS5289A (en) 1997-06-13 1999-12-08 Method of administration and method for the treatment of viral and microbial infections and corrosion syndromes

Country Status (34)

Country Link
EP (1) EP1011567A4 (en)
JP (1) JP4531141B2 (en)
KR (1) KR20010013709A (en)
CN (1) CN1260703A (en)
AP (1) AP1629A (en)
AR (1) AR012970A1 (en)
AU (1) AU7831598A (en)
BG (1) BG103997A (en)
BR (1) BR9810095A (en)
CA (1) CA2295176A1 (en)
CZ (1) CZ298510B6 (en)
EA (1) EA200000011A1 (en)
EE (1) EE9900562A (en)
ES (1) ES2161187B1 (en)
FI (1) FI19992648L (en)
GB (1) GB2341319B (en)
HU (1) HUP0003034A2 (en)
ID (1) ID23516A (en)
IL (2) IL133396A0 (en)
IS (1) IS5289A (en)
LT (1) LT4714B (en)
LV (1) LV12490B (en)
NO (1) NO996117L (en)
NZ (1) NZ501669A (en)
OA (1) OA11307A (en)
PL (1) PL196256B1 (en)
RO (1) RO121252B1 (en)
SI (1) SI20191A (en)
SK (1) SK172299A3 (en)
TN (1) TNSN98086A1 (en)
TR (1) TR200000540T2 (en)
WO (1) WO1998056325A1 (en)
YU (1) YU66099A (en)
ZA (1) ZA984649B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1638468T3 (en) * 2003-06-30 2008-01-31 Alza Corp Method for coating skin piercing microprojections
AP2006003648A0 (en) * 2003-12-05 2006-06-30 Namibia Medical Invest Pty Ltd Patch

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE60941B1 (en) * 1986-07-10 1994-09-07 Elan Transdermal Ltd Transdermal drug delivery device
US4855294A (en) * 1988-09-06 1989-08-08 Theratech, Inc. Method for reducing skin irritation associated with drug/penetration enhancer compositions
US5534260A (en) * 1989-02-23 1996-07-09 University Of Utah Percutaneous drug delivery system
US5028435A (en) * 1989-05-22 1991-07-02 Advanced Polymer Systems, Inc. System and method for transdermal drug delivery
US5624912A (en) * 1991-08-21 1997-04-29 Burcoglu; Arsinur Method of treating HIV infection and related secondary infections with defibrotide
ES2115756T3 (en) * 1992-02-20 1998-07-01 Merrell Pharma Inc SULPHONIC ACID DERIVATIVES USED IN THE TREATMENT OF VIRAL DISEASES.
GEP20012423B (en) * 1995-12-15 2001-05-25 Cryopreservation Tech Cc Composition for Organ Cryopreservation and Treatment of Viral and Bacterial Infections

Also Published As

Publication number Publication date
TNSN98086A1 (en) 2005-03-15
GB2341319B (en) 2002-02-27
WO1998056325A1 (en) 1998-12-17
LT4714B (en) 2000-10-25
JP4531141B2 (en) 2010-08-25
JP2002511862A (en) 2002-04-16
IL133396A0 (en) 2001-04-30
AP9901708A0 (en) 1999-12-31
NO996117D0 (en) 1999-12-10
BR9810095A (en) 2001-11-13
FI19992648A7 (en) 2000-02-03
AU7831598A (en) 1998-12-30
ES2161187A1 (en) 2001-11-16
NZ501669A (en) 2001-09-28
SK172299A3 (en) 2000-09-12
FI19992648L (en) 2000-02-03
EE9900562A (en) 2000-06-15
CA2295176A1 (en) 1998-12-17
GB2341319A (en) 2000-03-15
GB9929189D0 (en) 2000-02-02
AR012970A1 (en) 2000-11-22
IL133396A (en) 2006-10-05
AP1629A (en) 2006-07-11
LV12490B (en) 2000-12-20
ID23516A (en) 2000-04-27
ZA984649B (en) 1999-12-17
EP1011567A1 (en) 2000-06-28
EP1011567A4 (en) 2000-06-28
CN1260703A (en) 2000-07-19
TR200000540T2 (en) 2000-09-21
LT99148A (en) 2000-07-25
PL196256B1 (en) 2007-12-31
SI20191A (en) 2000-10-31
CZ298510B6 (en) 2007-10-24
HUP0003034A2 (en) 2000-12-28
YU66099A (en) 2002-10-18
LV12490A (en) 2000-06-20
ES2161187B1 (en) 2003-08-16
KR20010013709A (en) 2001-02-26
OA11307A (en) 2003-10-24
RO121252B1 (en) 2007-02-28
CZ9904473A3 (en) 2001-03-14
EA200000011A1 (en) 2000-08-28
NO996117L (en) 2000-02-11
BG103997A (en) 2001-07-31
PL338439A1 (en) 2000-11-06

Similar Documents

Publication Publication Date Title
NO994778L (en) Methods and Preparations for the Treatment of Inflammatory Bowel Syndrome
NO991700D0 (en) Benzimidazole-2-carbamates for the treatment of viral infections and cancer
ITTO950140A0 (en) APHERESIS PROCEDURE AND SYSTEM
NO20016277D0 (en) Systems and methods for aerolizing pharmaceutical formulations
NO980687D0 (en) System and method for perfusion hyperthermia treatment
NO994613D0 (en) Procedures and preparations for the treatment of sleep apnea
NO20003048D0 (en) Foldable wheelchair and wheelchair joints
DK199900790A (en) Process and plant for the treatment of milk
DK0991666T3 (en) Alpha-1-antitrypsin preparation and process for its preparation
NO20015542D0 (en) Process for the preparation and use of N-desmethylzopiclones
NO983641D0 (en) METHOD OF TREATMENT AND PHARMACEUTICAL PREPARATION
DK0815922T3 (en) Desulfurization and decarbonisation process
DK0839153T3 (en) Process for the preparation of peptides and N-carbamoyl protected peptides
NO20012963L (en) Process for the preparation of 3-alkanoylindoles and 3-alkylindoles
DK91793D0 (en) PROCEDURE FOR SURFACE TREATMENT, MEDICINES FOR EXERCISE AND APPLICATION
DK0751132T3 (en) Pyridazinone derivatives and processes for preparing the same
NO20004400D0 (en) Callback System and Internet Phone Procedure
NO20015772L (en) Compounds and methods for the treatment of post-traumatic stress syndrome
NO993437L (en) Switching device and method for using the switching device
NO20011537D0 (en) Chemokine receptor peptide vaccines for the treatment and prevention of diabetes
NO983512D0 (en) Means for the treatment and prevention of AIDS
NO991278L (en) Procedure and system for secure e-commerce
NO20010464L (en) Methods and Preparations for the Treatment of Gastroesophageal Reflux Syndrome
NO911008L (en) PROCEDURE AND PROCEDURE FOR MANUFACTURING THEREOF.
NO20000383L (en) Extension tube assembly and method of setting the same